M. Adiyev

M. Adiyev

Auto-generated profile, based on publicly available information

M. Adiyev

SCE on LEA «Almaty Regional Multidisciplinary Clinic

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2024 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
KTK. Tazhibayeva
K. Tazhibayeva
ASA. Sadykova
A. Sadykova
SOS. Olzhaev
S. Olzhaev
BAB. Adzhibaev
B. Adzhibaev
AMA. Mussina
A. Mussina
MAM. Adiyev
M. Adiyev
Relevance: Ovarian preservation in young women with early-stage endometrial cancer after surgical treatment has been conventionally associated with complications. Nevertheless, recent randomized studies suggest a different perspective. The study aimed to clarify the occurrence of complications, in particular relapses, associated with ovarian preservation in young women after hormonal and surgical treatment for early-stage endometrial cancer. Methods: The analysis included articles published in full text over the past 10 years. We identified relevant observations from studies using a comprehensive search in the following databases: PubMed, Medline, Embase, and Cochrane Library. The search strategy included terms related to endometrial cancer: premenopausal, young woman, endometrial cancer, ovarian conservation. The study followed the PRISMA guidelines for systematic reviews. Results: A total of 178 articles were studied, of which 111 articles (literature reviews and meta-analyses) (62%) described the cases of ovarian preservation. Of these, 84 were excluded for various reasons; 29 eligible articles were included in this analysis. Notably, factors such as younger age (P<0.0001), later year of diagnosis (P=0.03), residence in Central and Southern Europe and the United States (P=0.02), and lower-grade tumors in Asian countries (P<0.002) correlated with the desire of women to preserve their ovaries. The conducted literature review showed that ovarian preservation did not significantly affect cancer-specific survival (risk ratio (HR) =0.78, 95% CI 0.17-2.74) or overall survival (HR=0.78, 95% CI 0.24-1.75). This study’s results remained practically unchanged even after excluding women after radiation and hormone therapy. Conclusion: This literature review revealed no statistically significant difference in relapse-free survival between patients after ovarian preservation at stage IA and partially at stage II com-pared to those after bilateral salpingo-oophorectomy.